Navigation Links
BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
Date:11/15/2007

several months.

About BiPar Sciences

BiPar Sciences Inc. (http://www.biparsciences.com) is a clinical-stage biopharmaceutical company developing and commercializing a pipeline of novel, tumor-selective drugs designed to meet the significant unmet needs of cancer patients.

About the US Oncology Research Network

The US Oncology Research Network is an established community-based research operation specializing in all phases of cancer clinical trials. The research network currently has more than 536 physicians actively enrolling patients, 88 research sites, and is currently involved in 72 open research trials. The network has contributed to the development of 23 of 29 of the latest cancer-fighting drugs approved by the Food and Drug Administration for use. Since 1993, nearly 30,000 patients have participated in clinical trials managed by US Oncology network practices. For more information, visit the "Research" section under "Our Services" on the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE BiPar Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
4. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
5. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
6. Enrollment Begins on Human PK Study for Medidur(TM) FA
7. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
11. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The National ... operate the Center for Space Radiation Research (CSRR) under ... Boerma is an Associate Professor of Pharmaceutical Sciences within ... of Pharmacy Division of Radiation Health. She is located ... will direct a team of investigators working across four ...
(Date:7/22/2014)... Mass. , July 22, 2014  Decision Resources Group ... Canada will remain relatively stagnant at ... despite the fact that percutaneous coronary intervention (PCI) volumes are ... other developed markets, such as the United States ... will be largely driven by the increase in penetration of ...
(Date:7/22/2014)... , July 22, 2014  Decision Resources ... multiple sclerosis (MS) patients currently treated with ... have ever experienced flushing and/or gastrointestinal events ... patients are currently experiencing these side effects, ... effective medical management of such events. In ...
Breaking Medicine Technology:Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3
... May 26 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in ... its 2010 Annual Meeting of Stockholders and Open House on June 2 from ... , , , ... , , ...
... May 25 Otix Global, Inc. (Nasdaq: OTIX ), ... begun offering franchising opportunities to audiologists and audiometrists throughout Australia ... annual Audiological Society of Australia (ASA) conference in Darling ... American Academy of Audiology conference which is held in the U.S. ...
Cached Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at Its 2010 Annual Meeting of Stockholders and Open House 2Isis Pharmaceuticals to Present a General Corporate Update at Its 2010 Annual Meeting of Stockholders and Open House 3Otix Global to Offer Franchise Opportunities in Australia 2Otix Global to Offer Franchise Opportunities in Australia 3
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... who are obese during pregnancy may be more likely to ... suggests. "We found that, compared with children born from ... obese during pregnancy had up to 20 to 30 percent ... an assistant professor of pediatrics at Children,s Hospital of Pittsburgh. ...
(Date:7/22/2014)... hysterectomy using electric power morcellation, uterine cancers were present ... the procedure, according to a study published by ... in which the uterus is fragmented into smaller pieces, ... Despite the commercial availability of electric power morcellators for ... at the time of electric power morcellation (in this ...
(Date:7/22/2014)... heart disease, Dr. Ross Feldman says women are often in ... a men,s-only disease, however, data has shown that post-menopausal women ... and are less likely to be adequately diagnosed and treated. ... the British Journal of Clinical Pharmacology brings to ... helps to identify which women are more prone to heart ...
(Date:7/22/2014)... July 22, 2014 As reported on July ... caller request to name her favorite beauty products, “ Botox ... to say that “ Botox has changed my life” ... makeup chair preparing for her various, daily appearances. “Suddenly ... Ms. Ripa (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s ...
(Date:7/22/2014)... Rochelle, NY -- New guidelines on cholesterol treatment and ... double the risk of dying from atherosclerotic cardiovascular disease ... do women with a similar risk profile (based on ... The implications of this finding for when and how ... Editorial in Journal of Men,s Health , a ...
Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:Study examines presence of uterine cancers at the time of hysterectomy using morcellation 2Health News:Gene variant identified as a heart disease risk factor for women 2Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2
... TUESDAY, May 29 (HealthDay News) -- People with less than ... problems with their thinking skills later in life, according to ... researchers from Harvard University noted that people with more education ... thinking, or so-called "cognitive," skills, even if they had the ...
... HealthDay Reporter , MONDAY, May 28 (HealthDay News) -- Could ... friends sit around? A small study suggests it,s possible: ... they hung out with active kids, and the reverse was ... affect how active kids are, and it,s not clear whether ...
... for suspected HIV is critical, pre-exposure preventive treatment is ... in high-risk groups, states a review of evidence published ... "Although postexposure prophylaxis has a long history of success, ... in the course of infection ("treatment as prevention") are ...
... May 27 (HealthDay News) -- Boosting students, levels of ... says. Swedish researchers followed more than 200 schoolchildren, ... Some children were assigned to an intervention group that ... training in motor-physical skills such as balance and coordination. ...
... from the U.S. Preventive Services Task Force (USPSTF) advising ... cancer in healthy men are likely to encounter serious ... a survey by Johns Hopkins investigators. In ... found that while doctors agreed with older recommendations to ...
... factor receptor cousins mobilize a specialized protein to activate a ... in the May 25 issue of Cell . ... in breast cancer and activation of glucose metabolism (glycolysis), which ... survive. Their research focused on Skp2 E3 ligase, a ...
Cached Medicine News:Health News:Education May Protect Brain From Exposure to Solvents 2Health News:Key to More Active, Slimmer Kids: Friends 2Health News:Antiretroviral treatment for preventing HIV infection: an evidence review for physicians 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 3Health News:Skp2 activates cancer-promoting, glucose-processing Akt 2Health News:Skp2 activates cancer-promoting, glucose-processing Akt 3
The flexible endoscope was mainly developed for the pure neuroendoscopy. Due to the working channel it is ideal suitable for therapeutic indications e.g. subdural hematomas, cysts or intraventricular...
Bipolar gingivoplasty loop. Individual sterile packs....
... Performance Instrument System. It is the only ... electric power with the unparalleled high performance ... The advanced design of this instrument system ... cooling system, advanced control circuitry, and the ...
... is a high speed pneumatic ... dissection of bone, biometals, bioplastics ... not only provides speed 80,000 ... the control and precision that ...
Medicine Products: